Literature DB >> 21142830

Effect of degree of methoxylation and particle size on compression properties and compactibility of pectin powders.

Linda Salbu1, Annette Bauer-Brandl, Göran Alderborn, Ingunn Tho.   

Abstract

This study examines the effect of the degree of methoxylation (DM) and particle size on compression properties and compactibility of pectin powders. A powder classification system based on sequential handling of compression parameters was applied. A single size fraction (90-125 μm) of pectin powders with DM values ranging from 5-72% was studied. For DM 25%, the effect of different particle size fractions (180-250, 125-180, 90-125, 63-90, 45-63, <45 μm) were investigated. Compression parameters were derived based on time-resolved force-displacement data using Heckel, Kawakita and Shapiro equations. Volume-specific surface area was estimated for powders and tablets. Tablet tensile strength was determined. It was found that all pectin powders displayed low degrees of particle rearrangement and relatively low degrees of fragmentation (class IIA materials). Pectin particles were found to be relatively soft, with a tendency towards softer particles for pectins of higher DM. The overall variation in fragmentation and deformation behavior was limited. Both DM and initial particle size affected the tensile strength of pectin tablets. The difference in surface hydrophobicity caused by the DM was suggested as being responsible for the variation in the mechanical strengths. The study shows that pectin grades with DM ≤ 40% are potential direct compression excipients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21142830     DOI: 10.3109/10837450.2010.535831

Source DB:  PubMed          Journal:  Pharm Dev Technol        ISSN: 1083-7450            Impact factor:   3.133


  1 in total

1.  On the drug-loading capacity of pectin powder for direct compression.

Authors:  Ingunn Tho; Katharina Picker-Freyer; Linda Salbu; Annette Bauer-Brandl
Journal:  AAPS PharmSciTech       Date:  2012-04-18       Impact factor: 3.246

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.